Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Orexigen Therapeutics Inc

+ Add to Watchlist


4.9200 USD 0.0100 0.20%

As of 20:10:00 ET on 05/28/2015.

Company Profile for Orexigen Therapeutics Inc (OREX)

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system (CNS) disorders with an initial focus on obesity.

Contact Information

Orexigen Therapeutics Inc

3344 N. Torrey Pines Court
Suite 200
La Jolla, CA 92037
United States
Phone: 1-858-875-8600
Fax: 1-858-875-8650

Key Executives for Orexigen Therapeutics Inc (OREX)

Michael A Narachi "Mike"President/CEOTom CannellChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus & Financial OfficerHeather D TurnerSenior VP/Secretary/Gen Cnsl
Preston S KlassenExec VP:Global Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil